Advanced search

Report side effect

Report a suspected side effect or falsified product to the MHRA Yellow Card scheme.
Go to {yellow_card_logo} site
{arrow_up} Back to top

Caspofungin 50 mg powder for concentrate for solution for infusion

Active Ingredient:
Company:  
ATC code: 
J02AX04
{info_black}
About Medicine
The Patient Information Leaflet (PIL) is the leaflet included in the pack with a medicine.
{info_black}
Last updated on emc: 05 Jan 2023

Below is a text only representation of the Patient Information Leaflet (ePIL).

The text only version may be available in large print, Braille or audio CD. For further information call emc accessibility on {phone} 0800 198 5000. The product code(s) for this leaflet is: PL17780/0769.

Caspofungin 50 mg Powder for Concentrate for Solution for Infusion

PACKAGE LEAFLET: INFORMATION FOR THE PATIENT

CASPOFUNGIN 50 MG POWDER FOR CONCENTRATE FOR SOLUTION FOR INFUSION

caspofungin

Read all of this leaflet carefully before you or your child is given this medicine because it contains important information for you.
  • Keep this leaflet. You may need to read it again.
  • If you have any further questions, ask your doctor, nurse or pharmacist
  • If you get any side effects, talk to your doctor, nurse or pharmacist. This includes any possible side effects not listed in this leaflet (see section 4).

What is in this leaflet:

1. What caspofungin is and what it is used for
2. What you need to know before you are given caspofungin
3. How caspofungin is given
4. Possible side effects
5. How to store caspofungin
6. Contents of the pack and other information

1. WHAT CASPOFUNGIN IS AND WHAT IT IS USED FOR
What Caspofungin is

Caspofungin 50mg powder for concentrate for solution for infusion contains a medicine called caspofungin. This belongs to a group of medicines called anti-fungals.

What Caspofungin is used for

Caspofungin is used to treat the following infections in children, adolescents and adults:

  • serious fungal infections in your tissues or organs (called ‘invasive candidiasis’). This infection is caused by fungal (yeast) cells called Candida. People who might get this type of infection include those who have just had an operation or those whose immune systems are weak. Fever and chills that do not respond to an antibiotic are the most common signs of this type of infection.
  • fungal infections in your nose, nasal sinuses or lungs (called ‘invasive aspergillosis’) if other anti-fungal treatments have not worked or have caused side effects. This infection is caused by a mould called Aspergillus. People who might get this type of infection include those having chemotherapy, those who have had a transplant and those whose immune systems are weak.
  • suspected fungal infections if you have a fever and a low white cell count that have not improved on treatment with an antibiotic. People who are at risk of getting a fungal infection include those who have just had an operation or those whose immune systems are weak.

How Caspofungin works

Caspofungin makes fungal cells fragile and stops the fungus from growing properly. This stops the infection from spreading and gives the body’s natural defenses a chance to completely get rid of the infection.

2. WHAT YOU NEED TO KNOW BEFORE YOU ARE GIVEN CASPOFUNGIN
You must not be given caspofungin
  • if you are allergic to caspofungin or any of the other ingredients of this medicine (listed in section 6).

If you are not sure, talk to your doctor, nurse or pharmacist before you are given your medicine.

Warnings and precautions

Talk to your doctor, nurse or pharmacist before you are given Caspofungin:

  • if you are allergic to any other medicines
  • if you have ever had liver problems - you might need a different dose of this medicine
  • if you are already taking ciclosporin (used to help prevent organ transplant rejection or to suppress your immune system) - as your doctor may need to run extra blood tests during your treatment.
  • if you have ever had any other medical problem.

If any of the above applies to you (or you are not sure), talk to your doctor, nurse or pharmacist before you are given caspofungin.

Caspofungin may also cause Serious Cutaneous Adverse Reactions such as Stevens-Johnson Syndrome (SJS) and toxic epidermal necrolysis (TEN).

Other medicines and caspofungin

Tell your doctor, nurse or pharmacist if you are taking, have recently taken or might take any other medicines. This includes medicines obtained without a prescription, including herbal medicines. This is because caspofungin can affect the way some other medicines work. Also some other medicines can affect the way caspofungin works.

Tell your doctor, nurse or pharmacist if you are taking any of the following medicines:

  • ciclosporin or tacrolimus (used to help prevent organ transplant rejection or to suppress your immune system) as your doctor may need to run extra blood tests during your treatment;
  • some HIV medicines such as efavirenz or nevirapine;
  • phenytoin or carbamazepine (used for the treatment of seizures);
  • dexamethasone (a steroid);
  • rifampicin (an antibiotic).

If any of the above apply to you (or you are not sure), talk to your doctor, nurse or pharmacist before you are given caspofungin.

Pregnancy and breast-feeding

If you are pregnant or breast-feeding, think you may be pregnant or are planning to have a baby, ask your doctor, nurse or pharmacist for advice before using this medicine.

  • Caspofungin has not been studied in pregnant women. It should be used in pregnancy only if the potential benefit justifies the potential risk to the unborn baby.
  • Women given caspofungin should not breast-feed.

Driving and using machines

There is no information to suggest that caspofungin affects your ability to drive or operate machinery.

Caspofungin contains sodium

This medicine contains less than 1 mmol sodium (23 mg) per vial, that is to say essentially ‘sodium-free’.

3. HOW CASPOFUNGIN IS GIVEN

Caspofungin will always be prepared and given to you by a healthcare professional.

You will be given caspofungin:

  • once each day
  • by slow injection into a vein (intravenous infusion)
  • over about 1 hour

Your doctor will determine the duration of your treatment and how much caspofungin you will be given each day. Your doctor will monitor how well the medicine works for you. If you weigh more than 80 kg, you may need a different dose.

Use in children and adolescents

The dose for children and adolescents may differ from the adult dose.

If you have been given more caspofungin than you should

Your doctor will decide how much caspofungin you need and for how long each day. If you are worried that you may have been given too much caspofungin, tell your doctor or nurse straight away.

If you have any further questions on the use of this medicine, ask your doctor, nurse or pharmacist.

4. POSSIBLE SIDE EFFECTS

Like all medicines, this medicine can cause side effects, although not everybody gets them.

Tell your doctor or nurse straight away if you notice any of the following side effects as you may need urgent medical treatment:
  • rash, itching, feeling warm, swelling of your face, lips or throat or difficulty breathing - you may be having a histamine reaction to the medicine;
  • difficulty breathing with wheezing or a rash that gets worse - you may be having an allergic reaction to the medicine;
  • cough, serious breathing difficulties - if you are an adult and have invasive aspergillosis you may be experiencing a serious respiratory problem that could result in respiratory failure.
  • rash, skin peeling, mucous membrane sores, hives, large areas of peeling skin.

As with any prescription medicine, some side effects may be serious. Ask your doctor for more information.

Other side effects in adults include:

Common (may affect up to 1 in 10 people):

  • decreased haemoglobin (decreased oxygen carrying substance in the blood), decreased white blood cells;
  • decreased blood albumin (a type of protein) in your blood, decreased potassium or low potassium levels in the blood;
  • headache;
  • inflammation of the vein;
  • shortness of breath;
  • diarrhoea, nausea or vomiting;
  • changes in some laboratory blood tests (including increased values of some liver tests);
  • itching, rash, skin redness or sweating more than usual;
  • joint pain;
  • chills, fever;
  • itching at the injection site.

Uncommon (may affect up to 1 in 100 people):

  • changes in some laboratory blood tests (including disease of blood clotting, platelets, red blood cells and white blood cells);
  • loss of appetite, increase in amount of body fluid, imbalance of salt in the body, high sugar level in the blood, low calcium level in the blood, increased calcium level in the blood, low magnesium level in the blood, increase in acid level in the blood;
  • disorientation, feeling nervous, being unable to sleep;
  • feeling dizzy, decreased feeling or sensitivity (especially in the skin), shaking, feeling sleepy, change in the way things taste, tingling or numbness;
  • blurred vision, increase in tears, swollen eyelid, yellowing of the whites of the eyes;
  • sensation of fast or irregular heartbeats, rapid heartbeat, irregular heartbeat, abnormal heart rhythm, heart failure;
  • flushing, hot flush, high blood pressure, low blood pressure, redness along a vein which is extremely tender when touched;
  • tightening of the bands of muscle around the airways resulting in wheezing or coughing, fast breathing rate, shortness of breath that wakes you up, shortage of oxygen in the blood, abnormal breath sounds, crackling sounds in the lungs, wheezing, nasal congestion, cough, throat pain;
  • belly pain, upper belly pain, bloating, constipation, difficulty swallowing, dry mouth, indigestion, passing gas, stomach discomfort, swelling due to build-up of fluid around the belly;
  • decreased flow of bile, enlarged liver, yellowing of the skin and/or whites of the eyes, liver injury caused by a drug or chemical, liver disorder;
  • abnormal skin tissue, generalized itching, hives, rash of varying appearance, abnormal skin, red often itchy spots on your arms and legs and sometimes on the face and the rest of the body;
  • back pain, pain in an arm or leg, bone pain, muscle pain, muscle weakness;
  • loss of kidney function, sudden loss of kidney function;
  • catheter site pain, injection site complaints (redness, hard lump, pain, swelling, irritation, rash, hives, leaking of fluid from the catheter into the tissue), inflammation of vein at injection site;
  • increased blood pressure and alterations in some laboratory blood tests (including kidney electrolyte and clotting tests), increased levels of the medicines you are taking that weaken the immune system;
  • chest discomfort, chest pain, feeling of body temperature change, generally feeling unwell, general pain, swelling of the face, swelling of the ankles, hands or feet, swelling, tenderness, feeling tired.

Additional side effects in children and adolescents

Very common (may affect more than 1 in 10 people):

  • fever.

Common (may affect up to 1 in 10 people):

  • headache;
  • fast heart beat;
  • flushing, low blood pressure;
  • changes in some laboratory blood tests (increased values of some liver tests);
  • itching, rash;
  • catheter site pain;
  • chills;
  • changes in some laboratory blood tests.

Reporting of side effects

If you get any side effects, talk to your doctor or pharmacist. This includes any possible side effects not listed in this leaflet. You can also report side effects directly via the Yellow Card Scheme Website: www.mhra.gov.uk/yellowcard or search for MHRA Yellow Card in the Google Play or Apple App Store. By reporting side effects, you can help provide more information on the safety of this medicine.

5. HOW TO STORE CASPOFUNGIN

Keep this medicine out of the sight and reach of children.

Do not use this medicine after the expiry date which is stated on the carton and the vial after EXP. The expiry date refers to the last day of that month.

Unopened vials: store in a refrigerator at 2°C - 8°C.

Chemical and physical in-use stability has been demonstrated for up to 24 hours at 25°C or less and at 5 ± 3°C when reconstituted with water for injection. From a microbiological point of view, unless the method of opening/reconstitution/dilution precludes the risk of microbiological contamination, the product should be used immediately. This is because it does not contain any ingredients to stop the growth of bacteria. If not used immediately, in-use storage times and conditions prior to use are the responsibility of the user.

Chemical and physical in-use stability of the diluted patient infusion solution has been demonstrated for 48 hours at 2 to 8°C and at room temperature (25°C), when diluted with sodium chloride solution 9 mg/ml (0.9%), 4.5 mg/ml (0.45%), or 2.25 mg/ml (0.225%) for infusion, or lactated Ringer’s solution. From a microbiological point of view, the product should be used immediately. If not used immediately, in use storage times and conditions prior to use are the responsibility of the user and would normally not be longer than 24 hours at 2 to 8°C, unless reconstitution and dilution have taken place in controlled validated aseptic conditions.

Only a trained healthcare professional who has read the complete directions should prepare the medicine (please see below “Instructions of how to reconstitute and dilute caspofungin”).

Do not throw away any medicines via wastewater or household waste. Ask your pharmacist how to throw away medicines you no longer use. These measures will help protect the environment.

6. CONTENTS OF THE PACK AND OTHER INFORMATION
What Caspofungin 50mg powder for concentrate for solution for infusion contains:
  • The active substance is caspofungin.

Each 50 mg vial contains 50 mg caspofungin (as acetate).

After reconstitution in 10.5 ml of water for injection, 1 ml of the concentrate contains 5.2 mg caspofungin.

  • The other ingredients are sucrose, mannitol, glacial acetic acid and sodium hydroxide.

What Caspofungin Zentiva 50mg powder for concentrate for solution for infusion looks like and contents of the pack:

Caspofungin is a sterile, white to off-white lyophilised powder.

Each pack contains one vial (10 ml) of powder.

Marketing Authorisation Holder
Zentiva Pharma UK Limited
12 New Fetter Lane
London
EC4A 1JP
United Kingdom

Manufacturer
Pharmadox Healthcare Ltd
KW20A Kordin Industrial Park
Paola
PLA 3000
Malta

or

ELPEN PHARMACEUTICAL CO., INC
Marathonos Ave. 95
Pikermi Attiki
19009
Greece

or

Pharmathen S.A.
Dervenakion str.
Pallini
Attiki
153 51
Greece

This leaflet was last updated in November 2022

1065035394

Zentiva
Company image
Address
First Floor, Andrews House, College Road, Guildford, Surrey, GU1 4QB, UK
Medical Information Direct Line
+44 (0)800 090 2408
Customer Care direct line
+44 (0)844 8793 188
Medical Information e-mail
[email protected]